top of page

Teléfono: +918866862020

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

​Inicio >

Spegra Tablet 90N

Spegra Tablet 90N

Manufacturer/Marketed By : Emcure Pharmaceuticals Ltd

$149.20 $95.20

Spegra Tablet 90N is an advanced antiretroviral therapy designed to combat Human Immunodeficiency Virus (HIV) type-1, featuring a powerful combination of dolutegravir, emtricitabine, and tenofovir alafenamide. This medication is intended...

Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.

Dolutegravir 50 mg + Emtricitabine 200 mg + Tenofovir Alafenamide 25 mg

Active Pharmaceutical Ingredient

Spegra Tablet 90N

SKU Emcure Pharmaceuticals Ltd
Precio original

149,20 US$

Precio de oferta

95,20 US$

Spegra Tablet 90N is an advanced antiretroviral therapy designed to combat Human Immunodeficiency Virus (HIV) type-1, featuring a powerful combination of dolutegravir, emtricitabine, and tenofovir alafenamide. This medication is intended for use in adults and adolescents aged 12 years and older who weigh at least 40 kg, providing a crucial tool in managing HIV infections effectively. By targeting and inhibiting the replication of the virus, Spegra Tablet helps control viral load, thereby reducing the risk of progression to acquired immunodeficiency syndrome (AIDS). It is essential to adhere to prescribed dosages, as improper use can lead to drug resistance and treatment failure. Patients should be aware of potential side effects, which may include gastrointestinal disturbances and fatigue, and should discuss any concerns with their healthcare provider. Regular monitoring and follow-ups are critical to ensure optimal treatment outcomes and overall health. With its convenient formulation, Spegra Tablet 90N represents a significant step forward in HIV management, promoting a better quality of life for those affected by this virus.

Active Pharmaceutical Ingredient

Dolutegravir 50 mg + Emtricitabine 200 mg + Tenofovir Alafenamide 25 mg

​Usos

• Spegra tablet 90n is primarily utilized in the management of human immunodeficiency virus (HIV) infection. This medication plays a crucial role in suppressing the virus, thereby helping to maintain the immune system's functionality. By targeting the virus, Spegra tablet 90n aids in reducing the risk of progression to acquired immunodeficiency syndrome (AIDS). Patients often use this treatment as part of a comprehensive care plan.
• The effectiveness of Spegra tablet 90n in controlling HIV viral load makes it a vital option for those living with the virus. Regular use of this medication can lead to undetectable viral levels, which is essential for improving overall health and quality of life. Patients taking Spegra tablet 90n may experience fewer opportunistic infections as their immune system remains stronger. This medicine is often prescribed in conjunction with other antiretroviral therapies for optimal results.
• In addition to treating HIV infection, Spegra tablet 90n is integral for preventing HIV transmission among at-risk populations. When taken consistently, it reduces the viral load in the body, significantly lowering the chances of spreading the virus to sexual partners. This preventive aspect of Spegra tablet 90n is a critical component of public health strategies aimed at controlling the HIV epidemic. Healthcare providers may recommend this medication for individuals with high-risk behaviors.
• Spegra tablet 90n also supports long-term health management for individuals living with HIV. By maintaining viral suppression, this medication helps patients achieve a better prognosis and enhances their ability to lead a normal life. Regular follow-up and adherence to Spegra tablet 90n are essential for maximizing its benefits. The medication is often part of a holistic approach that includes lifestyle modifications and regular medical check-ups.

Beneficios

The main benefit of taking Spegra Tablet 90N helps to reduce the amount of HIV virus in the blood (viral load) and improve immune function and also helps to reduce the progression of HIV infection and reduce the risk of developing complications, such as AIDS. Taking Spegra Tablet 90N has a low risk of side effects compared to some other HIV medications. It is also easy to take, as it only needs to be taken once daily with food. Spegra Tablet 90N can help reduce the risk of transmitting HIV to others. This can help suppress the virus and reduce the amount of HIV in the body.

Efectos secundarios

Spegra Tablet 90N may cause some side effects. If you experience any of these side effects, contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.

Efectos secundarios más comunes

• Headache
• Cough
• Back Pain
• Cough
• Fatigue
• Insomnia

Efectos secundarios comunes

• Depression
• Skin Rashes
• Nightmares

​Cómo utilizar

Spegra Tablet 90N should be taken with a full glass of water. You can take it with or without food. Take this medicine exactly as prescribed by your doctor. Do not take more or less of the medication than directed. Do not crush, chew, or break it. If you miss a dose of this medicine, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and take your next dose at the regular time. Do not take two doses at the same time to make up for a missed dose.

Consejos de seguridad

• Alcohol: It is generally not recommended to drink alcohol while taking Spegra Tablet 90N. It may increase the risk of liver damage. It is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Spegra Tablet 90N is not recommended for use in patients with severe kidney disease. It is important to discuss all of your medical conditions and medications with your doctor to ensure that the treatment plan is safe and effective for you.
• Breastfeeding: It is not recommended to breastfeed while taking Spegra Tablet 90N. It may pass into breast milk and harm the infant. If you are breastfeeding and taking this tablet, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Spegra Tablet 90N is not recommended for use in patients with severe liver disease. It is important to discuss all of your medical conditions and medications with your doctor to ensure that the treatment plan is safe and effective for you.
• Pregnancy: Spegra Tablet 90N should only be used in pregnant women if recommended by the doctor after assessing the need and the risk. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Spegra Tablet 90N may cause dizziness, fatigue and sleepiness, which may affect your ability to drive or operate machinery. If you experience any side effects while taking this tablet such as dizziness or sleepiness, it is important to avoid driving or operating heavy machinery until the side effects have resolved.

​Descargo de responsabilidad

Sidmex Inovia se esfuerza por brindar información precisa y confiable; sin embargo, todo el contenido de este sitio web, incluidas las descripciones y composiciones de los productos, tiene fines meramente informativos y no debe considerarse un sustituto del consejo, diagnóstico o tratamiento médico profesional.

Se recomienda a los usuarios consultar con un profesional de la salud calificado antes de tomar cualquier decisión médica. La información proporcionada no debe utilizarse para el autodiagnóstico ni la automedicación.

Todos los productos listados están destinados exclusivamente a fines comerciales y consultas al por mayor. Sidmex Inovia no promueve el uso directo por parte del consumidor y su objetivo es apoyar, no reemplazar, la relación entre el profesional de la salud y el paciente.

Los nombres de productos, marcas registradas y marcas comerciales pertenecen a sus respectivos propietarios, y su uso no implica ninguna afiliación ni respaldo. Sidmex Inovia no se responsabiliza por las consecuencias derivadas del uso de la información proporcionada en este sitio web.

bottom of page